Dr. Maurie Markman highlights the upcoming "Stand Up to Cancer" event, a novel project designed to raise money to finance cancer research that might otherwise never find support. Medscape Hematology-Oncology
Plerixafor improves the mobilization of bone-marrow stem cells in healthy volunteers and substantially shortens the collection process. Medscape Medical News
Multi-modal treatment for invasive bladder cancer has been shown to be effective, however, definitive evidence is still lacking. Learn more about combination therapies and how they affect survival. Nature Clinical Practice Oncology
Drs. Bao and Wolff discuss the distinctions between these overlapping tumor phenotypes as well as recent data on treatment options. Medscape Hematology-Oncology
Is there a new role for EGFR inhibitors in the treatment of lung cancer? In this expert column, Dr. Neil and Dr. Heist review the latest data. Medscape Hematology-Oncology
A study shows that factors such as age at menopause and breast-feeding practices may influence the risk for the development of certain types of breast cancer. Medscape Medical News
In this interview, Dr. Belani reviews data from recent trials and offers insights into how these findings associating histology and response might affect the treatment of patients with NSCLC. Medscape Psychiatry & Mental Health
In this expert interview, Dr. Gary Hudes addresses prognostication and individualization of targeted and other therapies for patients with renal cell carcinoma as well as management of known and emerging toxicities. Medscape Hematology-Oncology
